ABVC BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ABVC BioPharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2023 | 2023-08-14 | $-0.68 | $-0.60 | -1333.3 % |
Mar 2023 | 2023-05-15 | $-0.60 | $-0.50 | -2000.0 % |
Dec 2022 | 2023-03-31 | $-1.50 | $-1.50 | 0.00 % |
Sep 2021 | 2021-11-15 | $-0.70 | $-0.40 | -7500.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2023 | 2023-08-14 | $6.11K | $300.00K | -98.0 % |
Mar 2023 | 2023-05-15 | $128.27K | $128.00K | 0.21 % |
Dec 2022 | 2023-03-31 | $588.99K | $10.00K | 5789.9 % |
Sep 2021 | 2021-11-15 | $99.00K | $190.00K | -47.9 % |
ABVC BioPharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
ABVC BioPharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.02, which missed the estimate of $0.00.
ABVC BioPharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.